FGF7/FGFR2--JunB signalling counteracts the effect of progesterone in luminal breast cancer.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 15, p. 2823, doi. 10.1002/1878-0261.13274
- By:
- Publication type:
- Article
Works matching IS 15747891 AND DT 2022 AND VI 16 AND IP 15
Results: 8
1
2
Corrigendum to: Imaging and cancer: a review.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 15, p. 2896, doi. 10.1002/1878-0261.13283
- Publication type:
- Article
3
RNA polymerase I inhibition induces terminal differentiation, growth arrest, and vulnerability to senolytics in colorectal cancer cells.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 15, p. 2788, doi. 10.1002/1878-0261.13265
- By:
- Publication type:
- Article
4
The SKP2-p27 axis de?nes susceptibility to cell death upon CHK1 inhibition.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 15, p. 2771, doi. 10.1002/1878-0261.13264
- By:
- Publication type:
- Article
5
Targeted inhibition of STAT3 induces immunogenic cell death of hepatocellular carcinoma cells via glycolysis.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 15, p. 2861, doi. 10.1002/1878-0261.13263
- By:
- Publication type:
- Article
6
PGAM1 regulation of ASS1 contributes to the progression of breast cancer through the cAMP/AMPK/CEBPB pathway.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 15, p. 2843, doi. 10.1002/1878-0261.13259
- By:
- Publication type:
- Article
7
NNK from tobacco smoking enhances pancreatic cancer cell stemness and chemoresistance by creating a β2AR-Akt feedback loop that activates autophagy.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 15, p. 2881, doi. 10.1002/1878-0261.13230
- By:
- Publication type:
- Article
8
In situ expression of ERG protein in the context of tumor heterogeneity identi?es prostate cancer patients with inferior prognosis.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 15, p. 2810, doi. 10.1002/1878-0261.13225
- By:
- Publication type:
- Article